Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling
Abstract Background Ovarian cancer is the fifth leading cause of cancer-related deaths amongst women in the United States. Cachexia is the primary cause of death in approximately 30% of cancer patients, and is often evidenced in ovarian cancer patients. We tested the steroidal lactone Withaferin A t...
Saved in:
Main Authors: | Alex R. Straughn (Author), Sham S. Kakar (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Withaferin A: a potential therapeutic agent against COVID-19 infection
by: Alex R. Straughn, et al.
Published: (2020) -
Withaferin A ameliorates ovarian cancer-induced renal damage through the regulation of expression of inflammatory cytokines
by: Kusum Kumar, et al.
Published: (2024) -
Cancer as a Proinflammatory Environment: Metastasis and Cachexia
by: Nelson Inácio Pinto, et al.
Published: (2015) -
Proinflammatory Cytokines IL-6 and TNF-α Increased Telomerase Activity through NF-κB/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells
by: Seyung S. Chung, et al.
Published: (2017) -
Withaferin A inhibits osteosarcoma cells through inactivation of Notch-1 signalling
by: Yang Chen, et al.
Published: (2014)